Skip to main content
Premium Trial:

Request an Annual Quote

Blueprint Initiative Announces Funding for Asian Branch, Launch of European Branch

NEW YORK, Aug 2 (GenomeWeb News) - The Blueprint Initiative said today that it has secured core funding to support the launch of Blueprint Asia in Singapore.


The Singapore effort, said Blueprint, will be supported by the Economic Development Board in partnership with the Genomics Institute of Singapore, the National University of Singapore, and industry partner Sun Microsystems. The exact amount of funding Blueprint Asia will receive was not disclosed.


"In June of 2004, we surpassed adding 80,000 interactions into the BIND database with curation activities underway at the Blueprint Initiative's headquarters in Canada," Christopher Hogue, a Blueprint principal investigator, said in a statement. "With the support for the Blueprint Initiative's Asian nodes, we will employ up to another 40 curators who will over five years enter an additional 60,000 biomolecular interactions."


Blueprint also announced today the launch of Blueprint Europe and its plan to partner with Nature Publishing Group to curate all biomolecular interactions across all titles in every manuscript published throughout the company's history.


Blueprint said that its European branch will provisionally be located in London while funding is pursued.


The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.